Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial

CONCLUSIONS: Ongoing depressive symptoms lead to poorer outcomes in POUD. Clinicians are encouraged to use integrative approaches to optimize treatment outcomes. This study was registered in ClinicalTrials.gov (NCT03033732) on January 27th, 2017, prior to participants enrollment.PMID:38580298 | DOI:10.1080/15504263.2024.2329267

Source: Journal of Dual Diagnosis - April 5, 2024 Category: Addiction Authors: Gabriel Bastien Anita Abboud Christina McAnulty Laurent Elkrief Omar Ledjiar M Eugenia Socias Bernard Le Foll Anees Bahji Suzanne Brissette St éphanie Marsan Didier Jutras-Aswad Source Type: research